moxifloxacin has been researched along with Rupture in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galley, HF; Lowes, DA; Murphy, MP; Wallace, C; Webster, NR | 1 |
1 other study(ies) available for moxifloxacin and Rupture
Article | Year |
---|---|
The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells.
Topics: Achilles Tendon; Anti-Infective Agents; Antioxidants; Aza Compounds; Cell Survival; Cells, Cultured; Ciprofloxacin; Fluoroquinolones; Humans; Intracellular Membranes; Membrane Potential, Mitochondrial; Mitochondria; Moxifloxacin; Organophosphorus Compounds; Oxidative Stress; Quinolines; Rupture; Tendinopathy; Ubiquinone | 2009 |